Fourth Quarter and Full Year 2019 Financial Results & Corporate Update PTC Therapeutics, Inc. Forward looking statement 2 This presentation contains forward -looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 . All statements contained in this presentation, other than statements of historic fact, are forward-looking statements, including statements with respect to 2020 net product revenue guidance, statements with respect to the 2020 non-GAAP R&D and SG&A expense g ...

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2019 Earnings Conference Call March 2, 2020 4:30 PM ET Company Participants Alex Kane - Head of Investor Relations Stuart Peltz - Chief Executive Officer Marcio Souza - Chief Operating Officer Emily Hill - Chief Financial Officer Conference Call Participants Alethia Young - Cantor Fitzgerald Joe Thome - Cowen and Company Martin Auster - Credit Suisse Vincent Chen - Bernstein Robyn Karnauskas - SunTrust Robinson Humphrey Sami Corwin - William Blair Gena Wang - Barclays ...

PTC 2020 JP Morgan Healthcare Conference Stuart W. Peltz, Ph.D., CEO Forward looking statement 2 This presentation contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this presentation, other than statements of historic fact, are forward-looking statements, including statements related to preliminary unaudited 2019 financial information with respect to 2019 net product revenue of Translarna for the treatment of nmDMD and ...